INFU — Infusystem Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual income statement for Infusystem Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	81.1	97.4	102	110	126
Cost of Revenue
Gross Profit	46.9	58.8	60.2	62.6	63.1
Selling / General / Administrative Expenses
Depreciation and Amortization
Total Operating Expenses	77.6	88.6	99.6	108	122
Operating Profit	3.52	8.83	2.82	1.65	4.09
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1.52	7.54	1.26	0.13	1.85
Provision for Income Taxes
Net Income After Taxes	1.36	17.3	1.42	0.018	0.872
Net Income Before Extraordinary Items
Net Income	1.36	17.3	1.42	0.018	0.872
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1.36	17.3	1.42	0.018	0.872
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.065	0.798	0.064	0.001	0.04